Skip to content

Clinical Study on the Establishment of a Severe Predictive Model and Prognostic Determination of Mycoplasma Pneumonia in Children

Clinical Study on the Establishment of a Severe Predictive Model and Prognostic Determination of Mycoplasma Pneumonia in Children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094114
Enrollment
Unknown
Registered
2024-12-17
Start date
2023-11-06
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycoplasma pneumoniae pneumonia

Interventions

Retrospective severe mycoplasma pneumoniae pneumonia group:None
Retrospective general mycoplasma pneumoniae pneumonia group:None
Prospective severe mycoplasma pneumoniae pneumonia group:None
Prospective general mycoplasma pneumoniae pneumonia group:None

Sponsors

Tianjin Children’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: For children with Mycoplasma pneumoniae pneumonia admitted from January 2015 to December 2021, the diagnostic criteria for mycoplasma infection were: MP-Ab1: above 160 by particle agglutination method; Sputum or alveolar lavage fluid polymerase chain reaction confirms Mycoplasma pneumoniae infection.

Exclusion criteria

Exclusion criteria: Patients who are immunodeficient or are using immunosuppressive drugs; Cases of mixed infection with other pathogens.

Design outcomes

Primary

MeasureTime frame
Pediatric Early Warning Score (PEWS);White blood cell;C-reactive protein;Interleukin-6;Interleukin-10;TNF-a;Lactate dehydrogenase (LDH);D-Dimer;Age;Gender;

Secondary

MeasureTime frame
Mycoplasma pneumoniae resistance gene;CD64;CD86;

Countries

China

Contacts

Public ContactZou Yingxue

Tianjin Children’s Hospital

zouyingxue2015@126.com+86 138 2157 9118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026